Low Cost Semi Automated Assembly Unit for Small Size Back Contact Modules and Low Cost Interconnection Approach

AbstractWe present our low cost assembly unit to manufacture back contact solar modules based on the conductive backsheet (CBS) approach. This in house developed apparatus was built to assemble test modules containing one up to four 6 inch back contact solar cells. The system is a retrofit of a commercially available CNC system which is equipped with a cell grabber and a manual dispensing system (by Nordson). The total cost of the setup was roughly 4000 € excluding the dispenser unit. Using this equipment we assembled several small size modules containing one and four Zebra cells, which are low cost 6 inch IBC solar cells developed at ISC Konstanz [1,2]. The contact between copper backsheet and back contact cell of the one cell modules we present here is formed by low temperature solder paste (LTSP). First cell to module (CTM) loss evaluations and reliability results suggest that this material could be a viable alternative to electrically conductive adhesive (ECA) which is currently the most commonly used material for this purpose

Frequency and Clinicopathological Profile Associated with Braf Mutations in Patients with Advanced Melanoma in Spain

Real-world data on BRAF mutation frequency in advanced melanoma are lacking in Spain. Moreover, data available on clinicopathological profile of patients with advanced BRAF-mutant melanoma are currently limited. This study aimed to assess the frequency of BRAF V600 mutations in Spanish patients with advanced or metastatic melanoma and to identify clinical and histopathological features associated with BRAF-mutated tumors. A multicenter, cross-sectional epidemiological study was conducted in 33 Spanish hospitals in adult patients with stage IIIc/IV melanoma. A total of 264 patients were included. The median age was 68 years and 57% were male. Melanoma mainly involved skin with intermittent (40.4%) and low or no sun exposure (43.5%). Most patients (85.6%) had stage IV disease (M1a: 19.3%; M1b: 13.3%; M1c: 22.7%). Serum lactate dehydrogenase levels were elevated in 20% of patients. Superficial spreading melanoma was the most frequent histological type (29.9%). Samples were predominantly obtained from metastases (62.7%), mostly from skin and soft tissues (80%). BRAF mutation analysis was primarily performed using the Cobas 4800 BRAF V600 Mutation Test (92.8%) on formalin-fixed, paraffin-embedded tissue (95.8%). BRAF mutations were detected in 41.3% of samples. Multivariate analysis identified age (odd ratio [OR] 0.975) and stage IV M1a (OR 2.716) as independent factors associated with BRAF mutation. The frequency of BRAF mutations in tumor samples from patients with advanced or metastatic melanoma in Spain was 41.3%. BRAF mutations seem to be more frequent in younger patients and stage M1a patients. This study provides the basis for further investigation regarding BRAF-mutated advanced melanoma in larger cohorts.This study was sponsored by Roche Farma S.A